SCHEMBL3265387

SCHEMBL3265387

NC(=O)N(S)c1ccccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
ALDH1A1 P00352 4/20 0.38
HSD17B10 Q99714 1/20 0.37
CYP1A2 P05177 1/20 0.37
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
POLB P06746 2/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
RORC P51449 1/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2589475 0.85 TSHR (0.41) ALDH1A1HSD17B10KMT2AKDM4ELMNA
SCHEMBL6256662 0.79 CES2 (0.41) CES2CES1ALDH1A1HSD17B10CYP1A2
SCHEMBL14053556 0.78 ALDH1A1 (0.40) CES2CES1ALDH1A1HSD17B10KMT2A
SCHEMBL1116304 0.78 CYP3A4 (0.36) ALDH1A1HSD17B10POLBKDM4ETSHR
SCHEMBL1116324 0.78 KDM4E (0.43) ALDH1A1HSD17B10POLBKDM4ELMNA
SCHEMBL3264512 0.78 ALDH1A1 (0.40) CES2CES1ALDH1A1HSD17B10CYP1A2
SCHEMBL653173 0.77 FSCN1 (0.51) ALDH1A1HSD17B10KDM4ETSHR
SCHEMBL2588967 0.77 ALDH1A1 (0.41) ALDH1A1HSD17B10KMT2APOLBKDM4E
SCHEMBL7995828 0.76 CES2 (0.39) CES2CES1ALDH1A1HSD17B10CYP1A2
SCHEMBL4919799 0.76 SIGMAR1 (0.42) ALDH1A1KMT2APOLBKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10711026-B2 Spinosyn derivatives as insecticides AGRIMETIS, LLC (US) 2020-07-14 US disclosed
EP-3344610-B1 SPINOSYN DERIVATIVES AS INSECTICIDES AGRIMETIS LLC (US) 2020-05-06 EP disclosed
US-20190309007-A1 SPINOSYN DERIVATIVES AS INSECTICIDES CORTEVA AGRISCIENCE LLC 2019-10-10 US disclosed
EP-3344610-A1 SPINOSYN DERIVATIVES AS INSECTICIDES Agrimetis, LLC (US) 2018-07-11 EP disclosed
WO-2017040882-A1 SPINOSYN DERIVATIVES AS INSECTICIDES AGRIMETIS, LLC (US) 2017-03-09 WO disclosed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
WO-2012162468-A1 THIAZOL DERIVATIVES AS PRO -MATRIX METALLOPROTEINASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2012-11-29 WO disclosed
US-20120302573-A1 METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION JANSSEN PHARMACEUTICA NV (BE) 2012-11-29 US disclosed
EP-1899335-B1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PF MEDICAMENT (FR) 2010-05-19 EP disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed
EP-1899335-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2008-03-19 EP disclosed
WO-2007003611-A1 PYRROLOQUINOLINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS PIERRE FABRE MEDICAMENT (FR) 2007-01-11 WO disclosed
US-4816235-A Silver and manganese recovery using acidified thiourea PESIC BATRIC (US) 1989-03-28 US disclosed
US-4778519-A Recovery of precious metals from a thiourea leach PESIC BATRIC (US) 1988-10-18 US disclosed
US-3994719-A Resins for separating heavy metals consisting of thiourea-group-containing macroporous vinyl aromatic crosslinked matrixes BAYER AKTIENGESELLSCHAFT (DT) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302573-A1 METHODS OF INHIBITING PRO MATRIX METALLOPROTEINASE ACTIVATION MMP13, MMP8, MMP11 CES2 1091/4885CES1 593/4885ALDH1A1 1395/4885
US-20190309007-A1 SPINOSYN DERIVATIVES AS INSECTICIDES SPIN3, ACHE, SPIN4 CES2 670/4885CES1 243/4885ALDH1A1 3794/4885
US-10711026-B2 Spinosyn derivatives as insecticides SPIN3, ACHE, SPIN4 CES2 670/4885CES1 243/4885ALDH1A1 3794/4885
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 CES2 3846/4885CES1 3628/4885ALDH1A1 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.